Johnson and johnson
Release of J&J jabs from SA plant hailed as major boost for Africa
Aspen Pharmacare said the first batch to be used in South Africa will be released from its Gqeberha production facility on Monday.
-
Inside the latest coronavirus global developments
India becomes the third country to officially pass 400,000 virus deaths - although many believe the toll may be more than a million - as the country's vast vaccination drive slows.
-
Naptosa hopeful that COVID-19 vaccinations for teachers can begin soon
Last week, the Education Department said that it was still in talks with the Health Department to see if teachers could get their jab before primary school pupils returned on a full-time basis at the end of next month.
-
COVID-19 vaccine-makers largely protected on side effects
Pharmaceutical companies making COVID-19 vaccines are largely protected legally in the event of harmful side effects, like blood clots that have been linked to jabs from AstraZeneca and Johnson & Johnson.
-
About 30 million J&J vaccines to be produced at Aspen facility - Ramaphosa
Ramaphosa was speaking on the side-lines of an inspection of the institution in Gqeberha on Monday afternoon.
-
Third batch of the J&J COVID vaccine arrives in SA, more expected this week
Vaccine trial co-lead Professor Linda-Gail Bekker said 50 inoculation sites have been identified as more front-line health workers line up to receive their jabs.
-
SA waiting for FDA approval of J&J vaccine for general use
The FDA said the vaccine is highly effective against COVID-19, including against the second variant identified in South Africa.
-
Touch down! Thousands of J&J vaccine doses land at OR Tambo
The plane carrying South Africa's second batch of the Johnson and Johnson vaccine has landed at the OR Tambo International Airport on Staurday morning.
-
SA's second batch of the J&J vaccine due to land at ORTIA today
The new doses will be taken to a central location in Gauteng and from there they will be dispatched to the vaccination cites across the country.
-
SA records 1,654 new COVID cases and 117 daily deaths
In the last 24 hours, 1,654 infections have also been reported, with more than 1.5 million positive cases identified since the start of the pandemic.
-
Johnson & Johnson vaccine highly effective against severe COVID: FDA
New documents released by the US Food and Drug Administration show that the Johnson & Johnson vaccine is highly effective against severe COVID-19, including against the variants identified in South Africa and Brazil.
-
Gray calls for patience with COVID-19 vaccine rollout after hospital confusion
At the weekend, doctors at the Steve Biko Academic Hospital claimed they were refused vaccines despite having appointments. Professor Glenda Gray said that many general practitioners arrived at the site without appointments.
-
Ramaphosa lauds 'robust' health sector as COVID-19 vaccine rollout under way
President Cyril Ramaphosa was among the first group of people to be vaccinated with the single-dose Johnson & Johnson COVID-19 vaccine in Khayelitsha on Wednesday.
-
SA rollout of the J&J COVID vaccine will be expedited - Prof Bekker
South Africa has secured 9 million doses of the J&J vaccine with the first consignment of 80,000 vials expected to arrive in the country next week.
-
Congo to start using J&J Ebola vaccine in November
The J&J vaccine will complement another vaccine manufactured by Merck, which has been administered to more than 225,000 people.
-
Johnson & Johnson must pay $8bn over drug side effect - jury
Johnson & Johnson and its subsidiary Janssen Pharmaceuticals were blamed as plaintiff Nicholas Murray told the Philadelphia court that the drug Risperdal, prescribed to treat schizophrenia and bipolar disorder, had made him grow breasts.
-
J&J liable for $572 million in Oklahoma opioid epidemic trial; shares rise
The state’s attorney general had filed the lawsuit, seeking $17 billion to address the impact of the drug crisis on Oklahoma.
-
Johnson & Johnson says Indian drug regulators visited facilities, took samples
The visits came as a probe is launched into J&J’s Baby Powder following a report that the firm knew that cancer-causing asbestos could be found in the product.
-
Johnson & Johnson ordered to pay $55m in talc-powder trial
A woman claimed using J&Js talc-powder for feminine hygiene caused her to develop ovarian cancer.
